Desh Rakshak Aushdhalaya Limited (BOM:531521)
India
· Delayed Price · Currency is INR 23.16
-1.21 (-4.97%)
At close: Mar 4, 2026
Desh Rakshak Aushdhalaya Revenue
Desh Rakshak Aushdhalaya had revenue of 13.97M INR in the quarter ending December 31, 2025, a decrease of -25.63%. This brings the company's revenue in the last twelve months to 57.72M, down -13.01% year-over-year. In the fiscal year ending March 31, 2025, Desh Rakshak Aushdhalaya had annual revenue of 62.71M with 4.37% growth.
Revenue (ttm)
57.72M
Revenue Growth
-13.01%
P/S Ratio
2.29
Revenue / Employee
2.89M
Employees
20
Market Cap
131.97M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 62.71M | 2.63M | 4.37% |
| Mar 31, 2024 | 60.08M | -1.72M | -2.79% |
| Mar 31, 2023 | 61.80M | -91.20K | -0.15% |
| Mar 31, 2022 | 61.89M | -4.09M | -6.19% |
| Mar 31, 2021 | 65.98M | 15.11M | 29.72% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ortin Global | 1.12M |
| Emmessar Biotech & Nutrition | 20.59M |
| Cian Healthcare | 232.80M |
| Norris Medicines | 94.44M |
| Hamps Bio | 71.20M |
| Zenith Healthcare | 113.86M |
| Colinz Laboratories | 58.40M |
| Beryl Drugs | 176.65M |